Day 1 Track 1 Session: Predictive Biomarkers and Companion Diagnostics for Immuno-Oncology
As immunotherapies becomes a backbone of cancer treatment, biomarker assays will be critical to optimizing the use of immunotherapies as single agent or in combinations. This panel will explore how leading biopharma and academic researchers are identifying biomarkers and developing companion diagnostics for immuno-oncology.
For more information go to: pmwcintl.com